X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC PHARMA with ALEMBIC LTD - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs ALEMBIC LTD - Comparison Results

ALEMBIC LTD 
   Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA ALEMBIC LTD ALEMBIC PHARMA/
ALEMBIC LTD
 
P/E (TTM) x 29.0 124.3 23.3% View Chart
P/BV x 6.6 4.6 143.4% View Chart
Dividend Yield % 0.7 0.2 292.8%  

Financials

 ALEMBIC PHARMA   ALEMBIC LTD
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-16
ALEMBIC LTD
Mar-16
ALEMBIC PHARMA/
ALEMBIC LTD
5-Yr Chart
Click to enlarge
High Rs79253 1,499.4%   
Low Rs44329 1,511.9%   
Sales per share (Unadj.) Rs167.04.7 3,538.8%  
Earnings per share (Unadj.) Rs38.28.8 435.0%  
Cash flow per share (Unadj.) Rs42.09.0 466.4%  
Dividends per share (Unadj.) Rs4.000.15 2,666.7%  
Dividend yield (eoy) %0.60.4 177.3%  
Book value per share (Unadj.) Rs84.927.7 306.2%  
Shares outstanding (eoy) m188.52267.03 70.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.78.7 42.5%   
Avg P/E ratio x16.24.7 345.8%  
P/CF ratio (eoy) x14.74.6 322.4%  
Price / Book Value ratio x7.31.5 491.1%  
Dividend payout %10.51.7 613.1%   
Avg Mkt Cap Rs m116,38310,962 1,061.7%   
No. of employees `000NANA-   
Total wages/salary Rs m4,214238 1,770.5%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m31,4871,260 2,498.4%  
Other income Rs m55264 20.9%   
Total revenues Rs m31,5421,524 2,069.6%   
Gross profit Rs m10,06083 12,149.5%  
Depreciation Rs m72261 1,176.1%   
Interest Rs m370 12,266.7%   
Profit before tax Rs m9,356285 3,284.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m-22,096 -0.1%   
Extraordinary Inc (Exp) Rs m0-32 0.0%   
Tax Rs m2,1606 35,413.1%   
Profit after tax Rs m7,1942,343 307.1%  
Gross profit margin %31.96.6 486.3%  
Effective tax rate %23.12.1 1,078.4%   
Net profit margin %22.8185.9 12.3%  
BALANCE SHEET DATA
Current assets Rs m15,0661,689 892.1%   
Current liabilities Rs m7,674486 1,578.4%   
Net working cap to sales %23.595.4 24.6%  
Current ratio x2.03.5 56.5%  
Inventory Days Days67217 30.9%  
Debtors Days Days4181 50.1%  
Net fixed assets Rs m8,2371,624 507.2%   
Share capital Rs m377534 70.6%   
"Free" reserves Rs m15,4165,960 258.7%   
Net worth Rs m16,0057,404 216.2%   
Long term debt Rs m0104 0.0%   
Total assets Rs m24,5948,010 307.0%  
Interest coverage x255.2950.7 26.8%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.30.2 813.7%   
Return on assets %29.429.3 100.5%  
Return on equity %44.931.6 142.1%  
Return on capital %58.731.3 187.5%  
Exports to sales %55.72.9 1,893.5%   
Imports to sales %10.428.9 36.1%   
Exports (fob) Rs m17,55137 47,306.7%   
Imports (cif) Rs m3,283364 902.7%   
Fx inflow Rs m17,81137 48,006.7%   
Fx outflow Rs m5,318365 1,457.2%   
Net fx Rs m12,493-328 -3,810.5%   
CASH FLOW
From Operations Rs m9,304346 2,692.1%  
From Investments Rs m-3,105-48 6,522.7%  
From Financial Activity Rs m-1,959-301 650.9%  
Net Cashflow Rs m4,240-3 -141,333.3%  

Share Holding

Indian Promoters % 74.1 64.0 115.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.9 0.2 1,450.0%  
FIIs % 9.1 9.7 93.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 13.9 26.1 53.3%  
Shareholders   49,328 54,701 90.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   TORRENT PHARMA  NATCO PHARMA  AJANTA PHARMA  SANOFI INDIA  DR. DATSONS LABS  

Compare ALEMBIC PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Firm; Healthcare & Metal Stocks Gain(09:30 am)

Asian stocks are higher today as Chinese and Hong Kong shares show gains. The Shanghai Composite is up 0.17% while the Hang Seng is up 0.95%. The Nikkei 225 is trading up by 0.4%.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

India's Rs 1,66,276 Crore Problem(Vivek Kaul's Diary)

Feb 15, 2018

That's the loss, the government owned public sector enterprises are expected to make this year.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

How I Beat the Index by 2x... And Why I Believe This Could Happen Again(Smart Contrarian)

Feb 12, 2018

Will Microcap Millionaires be able to replicate its past performance of beating the index by 2x?

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Feb 23, 2018 10:29 AM

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA - TTK HEALTHCARE COMPARISON

COMPARE ALEMBIC PHARMA WITH

MARKET STATS